# Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia

> **NCT00633659** · PHASE2 · COMPLETED · sponsor: **Sangart** · enrollment: 6 (actual)

## Conditions studied

- Vascular Disease
- Critical Lower Limb Ischemia

## Interventions

- **DRUG:** Hemospan (MP4OX)
- **DRUG:** Voluven (HES 130/0.4)

## Key facts

- **NCT ID:** NCT00633659
- **Lead sponsor:** Sangart
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-06
- **Final completion:** 2008-12
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2013-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00633659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00633659, "Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00633659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*